4//SEC Filing
Sandford Frederick J 4
Accession 0001683168-19-000083
CIK 0001367083other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 6:17 PM ET
Size
7.9 KB
Accession
0001683168-19-000083
Insider Transaction Report
Form 4
Sandford Frederick J
DirectorCEO and Interim CFO
Transactions
- Award
Stock option (right to buy)
2019-01-10+400,000→ 400,000 totalExercise: $0.72From: 2019-07-10Exp: 2029-01-10→ Common Stock (400,000 underlying) - Award
Stock option (right to buy)
2019-01-10+50,000→ 450,000 totalExercise: $0.72From: 2019-07-10Exp: 2029-01-10→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The options were granted to Mr. Sandford as an inducement stock option award in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement material to his entering into employment with the Issuer as Chief Executive Officer and Interim Chief Financial Officer.
- [F2]The options were granted to Mr. Sandford for his entering into employment with the Issuer as Chief Executive Officer and Interim Chief Financial Officer.
Documents
Issuer
Sonoma Pharmaceuticals, Inc.
CIK 0001367083
Entity typeother
Related Parties
1- filerCIK 0001599691
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 6:17 PM ET
- Size
- 7.9 KB